Werewolf Therapeutics Inc
Research Werewolf Therapeutics Inc (HOWL) on Bullrun: market cap USD 14.97M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerHOWL
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 14.97M
- Financial periodFY2025
- Net income-USD 60.82M
- Free cash flow-USD 60.29M
Valuation Snapshot
latest market cap is USD 14.97M.
About Werewolf Therapeutics Inc
Werewolf Therapeutics, Inc., a biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. The company designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies through its proprietary PREDATOR platform.
Frequently asked questions
What is Werewolf Therapeutics Inc's market cap?
Werewolf Therapeutics Inc's market capitalization is USD 14.97M.
What does Werewolf Therapeutics Inc do?
Werewolf Therapeutics, Inc., a biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions.